Mou Li

Dr. Mou Li

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
ZYZhiyuan Yu
Zhiyuan Yu
LMLu Ma
Lu Ma
JZJun Zheng
Jun Zheng
RGRui Guo
Rui Guo
MLMou Li
Mou Li
CYChao You
Chao You

22 July 2024 in Abdominal Radiology
Verified
Journal Article
Open access
PDF file
YCYazheng Chen
Yazheng Chen
TLTao Lu
Tao Lu
YZYongchang Zhang
Yongchang Zhang
HLHang Li
Hang Li
JXJingxu Xu
Jingxu Xu
MLMou Li
Mou Li
Purpose: To evaluate the performance of hepatobiliary MRI parameters as predictors of clinical response to chemotherapy in patients with initially unresectable colorectal cancer liver metastases (CRLM). Methods: Eighty-five patients with initially unresectable CRLM were retrospectively enrolled from two hospitals and scanned using gadobenate dimeglumine-enhanced MRI before treatment. Therapy response was evaluated based on the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. Conventional parameters (i.e., signal intensity [SI]) and radiomics features of portal venous phase (PVP) and hepatobiliary phase (HBP) images were analyzed between the responders and non-responders. Next, the combined model was constructed, and the area under the receiver operating characteristic (ROC) curve (AUC) was calculated. The relationship between the combined model and progression-free survival (PFS) was analyzed using Cox regression. Results: Of the 85 patients from two hospitals, 42 were in the response group, and 43 were in the non-response group. Upon conducting five-fold cross-validation, the normalized relative enhancement (NRE) of CRLM during the PVP yielded an AUC of 0.625. Additionally, a radiomics feature derived from the tumor area in the HBP achieved an AUC of 0.698, while a separate feature extracted from the peritumoral region in the HBP recorded an AUC of 0.709. The model that integrated these three features outperformed the individual features, achieving an AUC of 0.818. Furthermore, the combined model exhibited a significant correlation with PFS (P < 0.001). Conclusion: The combined model, based on baseline hepatobiliary MRI, aids in predicting chemotherapeutic response and PFS in patients with initially unresectable CRLM.

4 November 2022 in Medicine
Verified
Journal Article
Open access
YWYewu Mm Wang
Yewu Mm Wang
YJYumei Jin
Yumei Jin
MLMou Li
Mou Li
JZJun Zhang
Jun Zhang
SWShaoyu Wang
Shaoyu Wang
BSBin Song
Bin Song
Background: This meta-analysis aimed to explore the diagnostic value of diffusion kurtosis imaging (DKI) compared to mono-exponential diffusion weighted imaging (DWI) in the diagnosis of breast cancer. Methods: A systematic electronic literature search (up to September 2020) was conducted for published English-language studies comparing the diagnostic values of DKI and DWI for the detection of breast cancer. The data of mean kurtosis (MK), mean diffusivity (MD), and apparent diffusion coefficient (ADC) were extracted to construct 2 × 2 contingency tables. The pooled sensitivities, specificities, and areas under the receiver operating characteristic curve (AUCs) were compared between DKI and DWI in the diagnosis of breast cancer. Results: Eight studies were finally included, with a total of 771 patients in the same population. Pooled sensitivities were 82.0% [95% confidence interval (95% CI), 78.2‐85.3%] for ADC, 87.3% (95% CI, 83.9‐90.1%) for MK, and 83.9% (95% CI, 80.2‐87.1%) for MD. Pooled specificities were 81.1% (95% CI, 76.7‐84.9%) for ADC, 85.1% (95% CI, 81.1‐88.5%) for MK, and 83.2% (95% CI, 79.0‐86.8%) for MD. According to the summary receiver operator characteristic curve analyses, the AUCwas 0.901 for ADC, 0.930 for MK, and 0.918 for MD (ADC vs MK, P = .353; ADC vs MD, P = .611). No notable publication bias was found, while significant heterogeneity was observed. Conclusions: Although DKI is feasible for identifying breast cancer, MD and MK offer similar diagnostic performance to ADC values. Thus, we recommend that DKI should not be included in the routine evaluation of breast lesions now.

15 February 2023 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
TLTao Lu
Tao Lu
MLMou Li
Mou Li
YWYishuang Wang
Yishuang Wang
HLHang Li
Hang Li
MWMingpeng Wu
Mingpeng Wu
GWGuotai Wang
Guotai Wang